Emerald Medical Applications Corp. - Statements of Operations	3 Months Ended		6 Months Ended
	Jun. 30, 2016 USD ($) $ / shares shares	Jun. 30, 2015 USD ($) $ / shares shares	Jun. 30, 2016 USD ($) $ / shares shares	Jun. 30, 2015 USD ($) $ / shares shares
Statements of Operations
Revenue	$ 0	$ 0	$ 0	$ 0
Expenses:
Research and development	(192,002)	(237,095)	(295,350)	(247,400)
General and administrative expenses	(969,216)	(5,570)	(2,768,736)	(174,391)
Total operating expenses	$ (1,161,218)	$ (242,665)	$ (3,064,086)	$ (421,791)
(Loss) from operations	(1,161,218)	(242,665)	(3,064,086)	(421,791)
Other income (expense):
Interest expense	$ (14,128)	$ (4,346)	$ (21,887)	$ (11,829)
Change in fair value of derivative	0	0	0	367
Depreciation expense	(47,718)	0	(51,665)	0
Amortizatio expense	$ 28,587	$ 0	$ 28,587	$ 0
Gain/loss from foreign currency	6,503	(4,110)	20,847	1,808
Financial income (expense)	(26,756)	(8,456)	(24,118)	(9,654)
Total income (expense)	(1,187,974)	(251,121)	(3,088,204)	(431,445)
Provision for income taxes	0	0	0	0
Net (loss)	$ (1,187,974)	$ (251,121)	$ (3,088,204)	$ (431,445)
Basic and diluted net loss per share | $ / shares	$ (0.06)	$ (1.18)	$ (0.17)	$ (2.03)
Weighted average shares outstanding
Basic and diluted | shares	18,890,670	213,001	18,121,314	213,001